Home › Overweight › Florida › Doral
Overweight clinical trials in Doral, FL
6 studies for Overweight are looking for participants at sites in and around Doral (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RecruitingPhase 2
- Alliance for Multispecialty Research (AMR) Clinical Miami, Doral
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
RecruitingPhase 3
- Universal Axon Clinical Research LLC, Doral
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- AMR Clinical, Doral
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Doral
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RecruitingPhase 2
- DM Clinical Research, Doral
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
RecruitingPhase 1
- MBX Biosciences Investigational Site, Doral
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Dallas, TX23 studies
- Miami, FL23 studies
- Washington, DC20 studies
- Atlanta, GA20 studies
- Austin, TX19 studies
- Las Vegas, NV19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
Other studies in Doral
- Steatotic Liver Disease7 studies
- Obesity7 studies
- Type 2 Diabetes6 studies
- Alzheimer's Disease5 studies
- COPD4 studies
- Breast Cancer4 studies
- Depression3 studies
- Cirrhosis3 studies
- Atrial Fibrillation3 studies
- Blood Clots3 studies
- Graves Disease3 studies
- High Blood Pressure3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.